Prevention of Hyperalgesia With Epidural Morphine

Status Recruiting

Clinical Trial Summary

American Society of Anaesthesiologist physical status (ASA) I-III 105 patients who undergoing major abdominal surgery in obstetric and gynaecology clinic were recruited to this study. Patients were randomized into the 3 groups. Lumbar epidural catheter will be inserted to the all patients. After than anaesthesia induction will provide with 2 mg/kg propofol and 0.6 mg/kg rocuronium. Desflurane and azot protoxit (N2O)-O2 will use for anaesthesia maintenance. During surgical operation, 0.3 microgram/kg/h remifentanil infusion will continuous till the end of surgery. In group I, 2 ml serum physiologic (0.9 NaCL)will apply from epidural catheter before surgical incision. In group II, 1 mg morphine will apply from epidural catheter before surgical incision. In group III, 1 mg morphine will apply from epidural catheter at the time point of peritoneum is closed. Epidural patient controlled analgesia will provide with bupivacaine for postoperative analgesia. Postoperative pain will be assessed with numerical pain scale. Postoperative analgesic requirement will be calculated. Hyperalgesia will detect with algometer and von Frey ligaments.

Clinical Trial Description

This randomized, double blind, controlled study will perform after obtaining informed consent and ethics approval. American Society of Anaesthesiologist physical status (ASA) I-III 105 patients who undergoing major abdominal surgery in obstetric and gynaecology clinic were recruited to this study. Patients were randomized into the 3 groups with computerized randomization programme. Lumbar epidural catheter will be inserted to the all patients. After than anaesthesia induction will provide with 2 mg/kg propofol and 0.6 mg/kg rocuronium. Desflurane and N2O-O2 will use for anaesthesia maintenance. During surgical operation, 0.3 microgram/kg/h remifentanil infusion will continuous till the end of surgery. In group I, 2 ml serum physiologic (0.9 NaCL)will apply from epidural catheter before surgical incision. In group II, 1 mg morphine will apply from epidural catheter before surgical incision. In group III, 1 mg morphine will apply from epidural catheter at the time point of peritoneum is closed. Epidural patient controlled analgesia will provide with bupivacaine for postoperative analgesia. Postoperative pain will be assessed with numerical pain scale. Postoperative analgesic requirement will be calculated. Hyperalgesia will detect with algometer and von Frey ligaments. ;

Study Design

Related Conditions & MeSH terms

Hyperalgesia

Clinical Trial Details

NCT number	NCT03225690
Study type	Interventional
Source	Cukurova University
Contact	Ebru Biricik
Phone	5052420223
Email	ebrubiricik01@gmail.com
Status	Recruiting
Phase	Phase 4
Start date	July 19, 2017
Completion date	December 1, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01301079` - Evaluation of the Effect of Ketamine on Remifentanil-induced Hyperalgesia	Phase 3
Completed	`NCT00833755` - Effect of Ketamine on Opioid-Induced Hyperalgesia	N/A
Completed	`NCT00279032` - GW406381 In Patients With Peripheral Nerve Injury	Phase 1
Completed	`NCT03793790` - The Role of Learning in Nocebo Hyperalgesia	N/A
Completed	`NCT03985995` - Pain Response to Cannabidiol in Induced Acute Nociceptive Pain, Allodynia and Hyperalgesia By Using a Model Mimicking Acute Pain in Healthy Adults	N/A
Completed	`NCT04199858` - Electrophysiological Correlates of Nocebo Effects on Pain	N/A
Completed	`NCT02938455` - DNA Methylation and Perioperative Pain Treatment
Not yet recruiting	`NCT02934763` - Opioid Induced Hyperalgesia (OIH) Modulation With Propranolol	Phase 4
Completed	`NCT02653703` - L-menthol as a Topical Counter-irritant to TRPA1-induced Neurogenic Inflammation and Pain	N/A
Completed	`NCT02253966` - Preoperative Intraarticular Injection of Methylprednisolone in Patients Scheduled for Total Knee-arthroplasty	Phase 2
Terminated	`NCT01615510` - Evaluation of the Antihyperalgesic Effect of Tapentadol in Two Human Experimental Models	Phase 1
Completed	`NCT01702389` - Opioid-induced Hyperalgesia After Remifentanil Infusion	Phase 4
Completed	`NCT00218374` - Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced Hyperalgesia	N/A
Completed	`NCT00387413` - A Study Of GSK189254 And Duloxetine In The Electrical Hyperalgesia Model Of Healthy Volunteers	Phase 1
Completed	`NCT04197154` - Pain-related Fear as a Facilitator of Nocebo Hyperalgesia	N/A
Completed	`NCT02976337` - Effect of High-dose Naloxone Following Third Molar Extraction	Phase 2
Completed	`NCT03354624` - Cortical Neuroplasticity by Muscle Pain of Pain-induced Plasticity	N/A
Completed	`NCT02596360` - Dextromethorphan Effect on Central Sensitization to Pain in Healthy Volunteers	Phase 1
Recruiting	`NCT01480765` - Preventing Pain After Heart Surgery	Phase 4
Recruiting	`NCT01015482` - The Effect of High-dose Remifentanil on Established Sunburn-induced Hyperalgesia in Human Volunteers (HighDose RemiSun)	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.